Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:2108-2113
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veldtman, G. R.
Right arrow Articles by McLaughlin, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veldtman, G. R.
Right arrow Articles by McLaughlin, P. R.

CLINICAL STUDY: CONGENITAL HEART DISEASE

Right ventricular form and function after percutaneous atrial septal defect device closure

Gruschen R. Veldtman, MB, ChB*,1, Vanessa Razack*, Samuel Siu, MD, FACC*, Hassan El-Hajj, MB, ChB*, Fiona Walker, MB, ChB*, Gary D. Webb, MD, FACC*, Leland N. Benson, MD, FACC{dagger} and Peter R. McLaughlin, MD, FACC*

* Congenital Cardiac Centre for Adults, University of Toronto and Toronto General Hospital, Toronto, Ontario, Canada
{dagger} Division of Cardiology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada

Manuscript received October 10, 2000; revised manuscript received February 27, 2001, accepted March 22, 2001.

Reprint requests and correspondence: Dr. Peter R. McLaughlin, Congenital Cardiac Centre for Adults, University of Toronto, Toronto General Hospital, 200 Elizabeth Street, 12 EN, Room 224, Toronto, Ontario M5G 2C4, Canada
peter.mclaughlin{at}uhn.on.ca

OBJECTIVES

We sought to assess the right heart’s response to percutaneous device closure of moderate sized atrial septal defects (ASDs) in adults over a one-year follow-up period.

BACKGROUND

Percutaneous ASD device closure is a safe and effective means of reducing or eliminating interatrial shunting. The response of the adult’s right heart to device closure is incompletely understood.

METHODS

Forty consecutive patients had 40 device implantations (32 with the CardioSeal implant and 8 with the Amplatzer device). The patients were assessed with echocardiography, chest radiography and electrocardiography before the procedure and at 1, 6 and 12 months.

RESULTS

The mean ASD size was 13 ± 4 mm, and the device size ranged from 33 to 40 mm for CardioSeal and 12 to 36 mm for Amplatzer. At one month, heart size (49% vs. 46%), four-chamber right ventricular (RV) size (45 vs. 41 mm), paradoxical septal motion (60% vs. 5%), QRS duration (125 vs. 119 ms), PR interval (181 vs. 155 ms) and echocardiographically determined pulmonary artery systolic pressure decreased significantly and was maintained at 12-month follow-up. At six months, right atrial length decreased from 50 to 47 mm. At one year, 29% of patients had persistent RV enlargement.

CONCLUSIONS

Right heart morphology undergoes rapid improvement within one month of defect closure, with associated mechanoelectrical benefit. A small number of patients had persistent RV enlargement or pulmonary hypertension, or both, at one year. Our data support the application of transcatheter methods in achieving excellent hemodynamic and anatomic outcomes.

Abbreviations and Acronyms
  ASD = atrial septal defect
  ECG = electrocardiogram or electrocardiographic
  PA = pulmonary artery
  PSM = paradoxical septal motion
  RA = right atrium or atrial
  RV = right ventricle or ventricular
  RVOTD = right ventricular outflow tract diameter




This article has been cited by other articles:


Home page
Circ Cardiovasc IntervHome page
G. Yong, P. Khairy, P. De Guise, A. Dore, F. Marcotte, L.-A. Mercier, S. Noble, and R. Ibrahim
Pulmonary Arterial Hypertension in Patients With Transcatheter Closure of Secundum Atrial Septal Defects: A Longitudinal Study
Circ Cardiovasc Interv, October 1, 2009; 2(5): 455 - 462.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
G. Martucci and M. Landzberg
Not Just Big Kids: Closing Atrial Septal Defects in Adults Older Than 60 Years
Circ Cardiovasc Interv, April 1, 2009; 2(2): 83 - 84.
[Full Text] [PDF]


Home page
HeartHome page
O H Balint, A Samman, K Haberer, L Tobe, P McLaughlin, S C Siu, E Horlick, J Granton, and C K Silversides
Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure
Heart, September 1, 2008; 94(9): 1189 - 1193.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Inglessis and M. J. Landzberg
Interventional Catheterization in Adult Congenital Heart Disease
Circulation, March 27, 2007; 115(12): 1622 - 1633.
[Full Text] [PDF]


Home page
CirculationHome page
G. Webb and M. A. Gatzoulis
Atrial Septal Defects in the Adult: Recent Progress and Overview
Circulation, October 10, 2006; 114(15): 1645 - 1653.
[Full Text] [PDF]


Home page
HeartHome page
G Santoro, M Pascotto, S Caputo, F Cerrato, M Cappelli Bigazzi, M T Palladino, C Iacono, M Carrozza, M G Russo, and R Calabro
Similar cardiac remodelling after transcatheter atrial septal defect closure in children and young adults
Heart, July 1, 2006; 92(7): 958 - 962.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S P Schoen, T Kittner, S Bohl, M U Braun, G Simonis, A Schmeisser, and R H Strasser
Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: a magnetic resonance imaging study
Heart, June 1, 2006; 92(6): 821 - 826.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. Salehian, E. Horlick, M. Schwerzmann, K. Haberer, P. McLaughlin, S. C. Siu, G. Webb, and J. Therrien
Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects
J. Am. Coll. Cardiol., February 15, 2005; 45(4): 499 - 504.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C K Silversides, S C Siu, P R McLaughlin, K L Haberer, G D Webb, L Benson, and L Harris
Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients
Heart, October 1, 2004; 90(10): 1194 - 1198.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. D. Webb and E. M. Horlick
Lessons from cardiopulmonary testing after device closure of secundum atrial septal defects: A tale of two ventricles
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1892 - 1893.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Krumsdorf, S. Ostermayer, K. Billinger, T. Trepels, E. Zadan, K. Horvath, and H. Sievert
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients
J. Am. Coll. Cardiol., January 21, 2004; 43(2): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L Swan and M.A Gatzoulis
Closure of atrial septal defects: is the debate over?
Eur. Heart J., January 2, 2003; 24(2): 130 - 132.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J.W Roos-Hesselink, F.J Meijboom, S.E.C Spitaels, R van Domburg, E.H.M van Rijen, E.M.W.J Utens, A.J.J.C Bogers, and M.L Simoons
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age: A prospective follow-up study of 21-33 years
Eur. Heart J., January 2, 2003; 24(2): 190 - 197.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement